Chairmen by jolinmilioncherie


									Provided by

RogeRio C. LiLenbaum, mD, FaCP
Director, Thoracic Oncology Program
The Mount Sinai Cancer Center
Miami Beach, FL

maRk a. SoCinSki, mD
Multidisciplinary Thoracic Oncology Program
Lineberger Comprehensive Cancer Center
The University of North Carolina at Chapel Hill
Chapel Hill, NC
Statement of Need                                                                 Accreditation
Despite several decades of extensive research, the median survival                Physicians: The CBCE™ (The Center for Biomedical Continuing
for patients with advanced non–small cell lung cancer (NSCLC) and                 Education) is accredited by the Accreditation Council for Continuing
small cell lung cancer (SCLC) is approximately 1 year. Patients with              Medical Education (ACCME) to provide continuing medical education
early-stage NSCLC can sometimes be cured with surgical resection                  for physicians. This CME activity was planned and produced in
and chemotherapy, but the majority of patients present with advanced              accordance with the Essential Areas and policies of the ACCME.
disease, which makes local therapy impossible. Faced with these grim
statistics, investigators are seeking novel applications of imaging               The CBCE designates this educational activity for a maximum of 9.75
techniques as well as predictive and prognostic markers that will allow           AMA PRA Category 1 Credits™. Physicians should only claim credit
for early and more efficient treatment. Their extensive research has led          commensurate with the extent of their participation in this activity.
to steady advancements in recent years, including the development of
novel targeted and chemotherapeutic agents, enhanced approaches to                Physician Assistants: AAPA accepts category 1 credit from AOACCME,
standard treatments (such as novel radiation regimens and multimodali-            prescribed credit from AAFP, and AMA category 1 CME credit for the
ty therapies), and improvements in the adjuvant setting. This conference          PRA from organizations accredited by the ACCME.
will focus on the increased ability to diagnose and effectively treat
patients with lung cancer and will include overviews on imaging,                  Nurses: The CBCE™ (The Center for Biomedical Continuing Education)
radiotherapeutic, surgical, chemotherapeutic, and biologic strategies.            is accredited as a provider of continuing nursing education by the
Novel therapies and techniques currently undergoing development                   American Nurses Credentialing Center’s Commission on Accreditation.
will be emphasized. Results of recent research efforts, as well as the
design and rationale of ongoing studies and the optimization of these             The CBCE designates this educational activity for 9.75 contact
techniques for today’s clinical practice, will be presented and discussed.        hours. Accreditation by the American Nurses Credentialing Center’s
                                                                                  Commission on Accreditation refers to recognition of educational
Target Audience                                                                   activities and does not imply approval or endorsement of any product.
This activity is intended for medical, surgical, and radiation oncologists;
thoracic surgeons; pulmonologists; nurses; pharmacists; advanced
                                                                                  Pharmacists: The CBCE™ (The Center for Biomedical Continuing
practitioners; physician assistants; and other health care professionals
                                                                                  Education) is accredited by the Accreditation Council for Pharmacy
interested in the treatment of patients with lung cancer.
                                                                                  Education (ACPE) as a provider of continuing pharmacy education.
Educational Objectives                                                                 CPE Credit: 9.75 contact hours or 0.975 CEUs
After participating in this educational activity, attendees should be                  Universal Program Number: 195-000-07-020-L01-P
able to:
1. Assess the results of recent studies using radiologic imaging and
                                                                                  The Evaluation and Request for Credit Form must be completed and
   radiotherapy for the treatment of patients with NSCLC.
                                                                                  returned to the CBCE following this activity to obtain credit. Participants
2. Describe the standard of care for patients with early-stage NSCLC,
                                                                                  will receive their certificate 4-6 weeks after the CBCE receives their form.
   and discuss recent studies incorporating adjuvant and/or neoadjuvant
   chemotherapy into treatment regimens for patients eligible for surgery.        Acknowledgement of Commercial Support
3. Assess the efficacy of novel targeted approaches for the treatment of          The CBCE gratefully acknowledges educational grants provided by
   NSCLC based on the results of recent clinical trials.                          multiple commercial supporters. Please visit for a
4. Evaluate the safety and efficacy of recent trials investigating                current list of supporters.
   therapeutic strategies for patients with relapsed or progressive
                                                                                  Americans With Disabilities Act (ADA)
                                                                                  The CBCE fully complies with the legal requirements of the ADA and
5. Assess the results from recent studies aimed at identifying markers
                                                                                  the rules and regulations thereof. If any participant in this educational
   and patient characteristics that are predictive of response to specific
                                                                                  activity is in need of support services, please notify the CBCE staff at
   therapeutic agents.
                                                                                  the conference registration desk in order to receive service.
6. Describe the various surgical options for treating your patients with NSCLC.
7. Evaluate the results from recent clinical trials investigating the use of      Disclaimer
   novel agents or regimens for the treatment of patients with SCLC.              The content and views presented in this educational activity are those
8. Compare and contrast the safety and efficacy of current therapeutic            of the faculty and do not necessarily reflect the opinions or recommen-
   approaches to managing patients with unresectable malignant                    dations of the CBCE or the commercial supporters. This material has
   pleural mesothelioma.                                                          been prepared based on a review of multiple sources of information,
                                                                                  but is not exhaustive of the subject matter. Participants are advised to
Method of Participation
                                                                                  critically appraise the information presented, and are encouraged to
Lectures, visual aids, case presentations, audience response system,
                                                                                  consult the available literature on any product or device mentioned in
and discussion will be utilized to engage attendees and enhance the
                                                                                  this program.
learning process. All attendees will receive a comprehensive CD-ROM of
the program presentations approximately 4 weeks after the conference.
  RogeRio C. LiLenbaum, mD, FaCP
  Director, Thoracic Oncology Program
  The Mount Sinai Cancer Center
  Miami Beach, FL

  maRk a. SoCinSki, mD
  Multidisciplinary Thoracic Oncology Program
  Lineberger Comprehensive Cancer Center
  The University of North Carolina at Chapel Hill
  Chapel Hill, NC

WaLteR J. CuRRan JR, mD                             vinCent a. miLLeR, mD
Professor and Chairman                              Associate Attending Physician
Department of Radiation Oncology                    Memorial Sloan-Kettering Cancer Center
Jefferson Medical College
                                                    PauL L. moLina, mD
angeLa DavieS, mD                                   Professor of Radiology
Assistant Professor of Medicine                     The University of North Carolina at Chapel Hill
UC Davis Cancer Center
                                                    eDuaRDo C. oLiveiRa, mD, FCCP
ann FiSh-SteagaLL, bSn, Rn, oCn                     Chief of Medicine
Clinical Coordinator, MTOP                          Cleveland Clinic Florida
The University of North Carolina at Chapel Hill
                                                    haRvey i. PaSS, mD
naSSeR hanna, mD                                    Professor of Cardiothoracic Surgery
Associate Professor of Medicine                     Chief, Division of Thoracic Surgery
Indiana Cancer Pavillion                            NYU School of Medicine

DaviD h. haRPoLe JR, mD                             Roman PeRez-SoLeR, mD
Professor of Surgery                                Gutman Professor of Medicine, Chairman of Oncology
Vice-Chairman for Faculty Affairs and Education     Albert Einstein College of Medicine, Montefiore Medical Center
Department of Surgery
Duke University Medical Center                      m. PatRiCia RiveRa, mD, FCCP
                                                    Associate Professor of Medicine
heDy Lee kinDLeR, mD                                The University of North Carolina at Chapel Hill
Associate Professor of Medicine
Director of Gastrointestinal Oncology and           aLan b. SanDLeR, mD
Mesothelioma Programs                               Associate Professor of Medicine
The University of Chicago                           Vanderbilt-Ingram Cancer Center

maRk g. kRiS, mD                                    geRaRD SiLveStRi, mD
Chief, Thoracic Oncology Service                    Associate Professor of Medicine
Memorial Sloan-Kettering Cancer Center              Medical University of South Carolina

thomaS J. LynCh JR, mD                              geoRge Simon, mD
Associate Professor of Medicine                     Associate Professor
Massachusetts General Hospital Cancer Center        H. Lee Moffitt Cancer Center and Research Institute

homeR a. maCaPinLaC, mD                             eveRett e. vokeS, mD
Professor and Chairman, Nuclear Medicine            Director, Section of Hematology/Oncology
The University of Texas                             The University of Chicago
M. D. Anderson Cancer Center
Friday, March 14, 2008
4:00-6:30     PM       Registration
6:30-7:00     PM       Welcome Reception
7:00-7:45     PM       Keynote Lecture: moving toward Personalized                 Mark G. Kris
                       therapy for Lung Cancer: how Close are We?
7:45-8:00     PM       Question-and-answer Session
8:00-10:00        PM   Welcome Dinner

Saturday, March 15, 2008
7:00-8:00     AM       Registration and breakfast
8:00-8:05     AM       Welcome and introductions                                   Rogerio C. Lilenbaum

Session I: Diagnosis and Management of Early-Stage Lung Cancer                     Moderator: Paul L. Molina
8:05-8:10    AM        Case Study: Diagnosis and Preoperative assessment           Paul L. Molina
8:10-8:30    AM        Recent Developments in Lung Cancer imaging: Pet             Homer A. Macapinlac
8:30-8:50     AM       updates in invasive Staging Procedures                      Eduardo C. Oliveira
8:50-9:10    AM        Preoperative assessment of Pulmonary Function               Gerard Silvestri
9:10-9:15    AM        Case Study Continues: node Positive                         Paul L. Molina
9:15-9:35    AM        What is the Role for Limited Resection?                     David H. Harpole Jr
9:35-9:55    AM        adjuvant Chemotherapy                                       Thomas J. Lynch Jr
9:55-10:15    AM       Case Study Conclusion and Panel Discussion                  Moderator: Paul L. Molina
10:15-10:30       AM   break

Session II: Strategies for Stage III Disease                                       Moderator: Mark A. Socinski
10:30-10:40       AM   Case Study: Positive mediastinoscopy                        Mark A. Socinski
10:40-11:00       AM   Role of Surgery in Stage iii Disease                        Harvey Pass
11:00-11:20   AM       multimodality therapy for management of Stage iii Disease   Everett E. Vokes
11:20-11:40   AM       Practical issues in Radiation therapy                       Walter J. Curran Jr
11:40 A M - 12:00 P M Case Study Conclusion and Panel Discussion                   Moderator: Mark A. Socinski
12:00-12:15   PM       break and move to breakouts

Interactive Breakouts With Lunch
12:15-1:15   PM        medical oncology breakout: Case Studies From                Rogerio C. Lilenbaum and
                       Conference attendees                                        Mark A. Socinski
12:15-1:15   PM        therapeutic advances in Pulmonary management                M. Patricia Rivera
                       of Patients With Lung Cancer
12:15-1:15   PM         Radiotherapy in Patients With Lung Cancer: Problems          Speaker Invited
                        and Progress
12:15-1:15   PM         Challenges and advances in Surgical approaches to            Harvey Pass
                        treating Patients With Lung Cancer
12:15-1:15   PM         nursing initiatives and multidisciplinary Coordination       Ann Fish-Steagall

Sunday, March 16, 2008
7:00-8:00     AM        Registration and breakfast
8:00-8:05     AM        general Session Comments and introductions                   Mark A. Socinski

Session III: Selected Topics in the Treatment of Thoracic Malignancies Moderator: Mark A. Socinski
8:05-8:15     AM        Case Study: extensive-Stage and Limited-Stage Disease        Mark A. Socinski
8:15-8:35    AM         update on Small Cell: Limited- and extensive-Stage Disease   George Simon
8:35-8:50     AM        Case Study Conclusion and Panel Discussion                   Moderator: Mark A. Socinski
8:50-9:10     AM        update on mesothelioma                                       Hedy Lee Kindler
9:10-9:15    AM         Question-and-answer Session
9:15-9:35    AM         update on vaccines and gene therapy                          Angela Davies
9:35-9:40     AM        Question-and-answer Session
9:40-10:00        AM    Practical issues of egFR therapy                             Roman Perez-Soler
10:00-10:05        AM   Question-and-answer Session
10:05-10:20       AM    break

Session IV: Management of Advanced NSCLC                                             Moderator: Rogerio C. Lilenbaum
10:20-10:30       AM    Case Study: advanced nSCLC                                   Rogerio C. Lilenbaum
10:30-10:50       AM    Current Standards for First-Line therapy of                  Alan B. Sandler
                        advanced nSCLC
10:50-11:10   AM        Patient Selection Strategies for nSCLC: Clinical             Vincent A. Miller
11:10-11:20   AM        Case Study: Progression                                      Rogerio C. Lilenbaum
11:20-11:40   AM        Second- and third-Line treatment options in                  Nasser Hanna
                        advanced nSCLC
11:40 A M - 12:00 P M emerging targets for Lung Cancer: new alternatives             Speaker Invited
                      for the Future
12:00-12:20       PM    Case Study Conclusion and Panel Discussion                   Moderator: Rogerio C. Lilenbaum
12:20-12:35       PM    evaluation Completion
12:35   PM              adjourn
Conference Location:
Trump International Sonesta Beach Resort                         Climate
18001 Collins avenue                                             The climate in Sunny Isles Beach, Florida, in March consists
Sunny isles beach, FL 33160                                      of temperatures ranging from an average daily low of                                       66˚F to an average daily high of 75˚F. A light jacket is
                                                                 recommended for evening activities.

Group Rate
Room accommodations for this conference are $329 per             Limousine and Rental Car Services
night, single or double occupancy, with an approximate           Reservations can be made through Trump International
13% tax. A nightly resort service fee of $15 per room,           Sonesta Beach Resort concierge by calling (305) 692-5600.
taxable at 7%, will be added to each night of accommodation.
The resort fee includes entrance to the spa, utilization of
the fitness center, complimentary local calls (up to 20
minutes per call), access fees waived for credit card and
                                                                 Valet parking is available at Trump International Sonesta
800 calls, 10 pages of incoming faxes per day, in-room
                                                                 Beach Resort for $12 per day, and overnight parking is
coffee replenished daily, morning newspaper, beach and
                                                                 $24 plus tax.
pool chairs and umbrellas as well as pool and beach
attendant gratuities, Just Us Kids Club, and scheduled
shuttle service to Aventura Mall, Ball Harbour Shops,
and South Beach.                                                 Taxi
                                                                 If you wish to take a taxi to the hotel, expect a fare of
There will be an additional charge of $25 per day for            approximately $52–$55 from the Miami airport and $45
each additional person over the age of 18. The maximum           from the Ft. Lauderdale airport. A shuttle service is also
number of people per guest room is 4. A maximum of 2             available from both airports for approximately $25.
children under the age of 18 per room are complimentary.

                                                                 Conference Cancellation Policy
Reservation Guarantee                                            If a cancellation notice is received in writing by February
An early response is suggested for guests desiring the           14, 2008, 75% of the registration fee will be refunded. All
group rate. To ensure the group rate, reservations must          cancellation requests should be sent to the CBCE at the
be made through the CBCE by Friday, February 8, 2008.            address on the next page.
After February 8, 2008, no guarantee is provided for
accommodation availability or our room rate at Trump
International Sonesta Beach Resort.* Room type and
group room rate is subject to availability. Check-in time is
4:00 P M ; check-out time is 11:00 A M . All reservations must
be guaranteed with a 1-night room deposit or a major
credit card. A credit card is necessary to guarantee a
late arrival. All major credit cards are accepted by Trump
International Sonesta Beach Resort.
*If needed, the CBCE will make appropriate overnight
accommodations for you at a nearby property (subject
to availability).

Hotel Cancellation Policy
No-shows will be charged the full amount of the reservation.
Any guaranteed rooms cancelled less than 14 days prior
to the day of arrival will be charged the 1-night deposit
amount. If the hotel is able to resell the reservation, you
will not be charged the cancellation fee.
Conference Registration and Hotel Reservation Form
To register or for further information, please                  Registrations will be confirmed via e-mail or
complete the form below and fax or mail to:                     fax. Please provide the requested information about your e-mail
                                                                and fax number so that a confirmation may be sent to you.
the CbCe                                                        Your registration is not complete until you receive a confirmation.
1707 Market Place Boulevard, Suite 370                          Please contact the CBCE via phone, (214) 260-9024, or e-mail,
Irving, TX 75063                                      , if you have not received a confirmation within
Fax: (214) 260-0408 or                                          3 business days of your registration submission.
register online at

Registration Fees:           The registration fee covers participation at all conference sessions, meeting materials,
                             and food functions per the agenda.
O Physician, nurse, and pharmacist early-bird registration (in practice or academic research, registrations must be received and
  paid in full by Friday, January 18, 2008): $50.00
O Physician (in practice or academic research): $150.00
O nurse, pharmacist, and other health care professionals (in practice or academic research): $75.00
O Fellow (in practice or academic research): Complimentary
O industry/all others: $2,495.00 (This category is defined by the CBCE as any person employed by a for-profit organization,
  including biotech, financial, and pharmaceutical.)

Hotel Accommodations                 (A credit card is needed to reserve hotel accommodations.)
  O I am requesting hotel accommodations and                     O I do not need hotel accommodations.
    acknowledge the hotel cancellation policy.

  Check-in date:                                                 Check-out date:

  Preregister for early check-in (if available), requested check-in time:
  Room requested (upon availability):
  O King                             O Double
  O Nonsmoking                       O Smoking

O Mr   O Ms   O MD    O DO     O PhD    O PharmD     O Fellow    O RN    O Other:

Last Name                                                                   First Name

Institute                                                                   Title

Address (No P.O. Boxes)

City                         State                                          Zip/Postal Code

Telephone                                                                   Fax                  E-mail

(Signature indicates that you understand, accept, and will abide by all conference and hotel guidelines.)

Method of Payment for Conference Registration and/or Hotel Accommodations
O Check (Please make payable to: the CBCE)         O Credit Card:        O Visa        O MasterCard         O Discover   O AMEX

Card Number                                          Expiration Date                  Authorization Signature

If you require special accommodations to participate in this educational activity, please note your needs below:
(The CBCE fully complies with the legal requirements of the Americans With Disabilities Act and the rules and regulations thereof.)
                                       prsrt std
                                      Us pOstAGE
                                      AddIsON, tX
1707 Market Place Blvd. | Suite 370     pErMIt 6
Irving, TX 75063

To top